Search Results - "Nydam, Thomas"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer by Rathkopf, Dana E., Picus, Joel, Hussain, Arif, Ellard, Susan, Chi, Kim Nguyen, Nydam, Thomas, Allen-Freda, Erin, Mishra, Kaushal Kishor, Porro, Maria Grazia, Scher, Howard I., Wilding, George

    Published in Cancer chemotherapy and pharmacology (01-09-2013)
    “…Purpose Panobinostat, a pan-deacetylase inhibitor, increases acetylation of proteins associated with growth and survival of malignant cells. This phase 2 study…”
    Get full text
    Journal Article
  2. 2

    Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation by Nydam, T, Wade, T K, Yadati, S, Gabriel, J L, Barisas, B G, Wade, W F

    Published in International immunology (01-08-1998)
    “…The recent solutions of the MHC class II crystal structure reveal dimerization of the alphabeta heterodimers. These dimer of dimers structures may also exist…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients by Clive, Sally, Woo, Margaret M., Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark

    Published in Cancer chemotherapy and pharmacology (01-10-2012)
    “…Purpose Elucidating the metabolic profile of anticancer agent panobinostat is essential during drug development. Disposition, metabolism, and excretion…”
    Get full text
    Journal Article
  6. 6

    Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled super(14)C material in advanced cancer patients by Clive, Sally, Woo, Margaret M, Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark

    Published in Cancer chemotherapy and pharmacology (01-10-2012)
    “…Purpose: Elucidating the metabolic profile of anticancer agent panobinostat is essential during drug development. Disposition, metabolism, and excretion…”
    Get full text
    Journal Article
  7. 7

    Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled ^sup 14^C material in advanced cancer patients by Clive, Sally, Woo, Margaret M, Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark

    Published in Cancer chemotherapy and pharmacology (01-10-2012)
    “…Elucidating the metabolic profile of anticancer agent panobinostat is essential during drug development. Disposition, metabolism, and excretion profiles were…”
    Get full text
    Journal Article
  8. 8

    Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy by Chirichella, Thomas J, Dunham, C Michael, Zimmerman, Michael A, Phelan, Elise M, Mandell, M Susan, Conzen, Kendra D, Kelley, Stephen E, Nydam, Trevor L, Bak, Thomas E, Kam, Igal, Wachs, Michael E

    Published in World journal of gastroenterology : WJG (28-03-2016)
    “…AIM: To evaluate donation after circulatory death(DCD) orthotopic liver transplant outcomes [hypoxic cholangiopathy(HC) and patient/graft survival] and donor…”
    Get full text
    Journal Article
  9. 9

    Salt bridge residues between I-A k dimer of dimers α-chains modulate antigen presentation by Yadati, Shyam, Nydam, Thomas, Demian, Doug, Wade, Terri K, Gabriel, Jerome L, Barisas, B.George, Wade, William F

    Published in Immunology letters (1999)
    “…Class II dimers of dimers are predicted to have functional significance in antigen presentation. The putative contact amino acids of the I-A k class II dimer…”
    Get full text
    Journal Article
  10. 10

    Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation by Yadati, S, Nydam, T, Demian, D, Wade, T K, Gabriel, J L, Barisas, B G, Wade, W F

    Published in Immunology letters (15-03-1999)
    “…Class II dimers of dimers are predicted to have functional significance in antigen presentation. The putative contact amino acids of the I-Ak class II dimer of…”
    Get full text
    Journal Article